Literature DB >> 11385005

Prospective study of hallucinations and delusions in Parkinson's disease.

S Holroyd1, L Currie, G F Wooten.   

Abstract

OBJECTIVE: This study was undertaken to determine the prevalence of hallucinations and delusions in Parkinson's disease, to describe such symptoms phenomenologically, and possibly to determine factors associated with their development. In addition, the role of the visual system in relation to visual hallucinations was examined.
METHOD: 102 consecutive patients diagnosed with strictly defined Parkinson's disease were examined for the presence of hallucinations and delusions and assessed for visual acuity, cognition, depression using the geriatric depression scale, disease severity as measured by the UPDRS, and other clinical variables.
RESULTS: Of 102 consecutive patients, 29.4% (n=30) had hallucinations or delusions, four (3.9%) were determined to be psychotic due solely to delirium and were excluded from further analysis. Of the 98 remaining patients, 26.5% (n=26) had visual hallucinations. Among these, one patient also had delusions, two had auditory hallucinations, and one had gustatory hallucinations. Visual hallucinations were significantly associated with worse visual acuity, lower cognitive score, higher depression score, and worse disease severity. Hallucinations were not associated with history of psychiatric disease, dose or duration of levodopa or other antiparkinsonian medication treatment, or duration of illness.
CONCLUSIONS: Visual hallucinations are common symptoms in Parkinson's disease and are most likely of multifactorial origin. Although higher doses of levodopa are known to be related clinically to hallucinations in individual patients, the results suggest that several underlying characteristics of patients with Parkinson's disease (disease severity, dementia, depression, worse visual acuity) may be more important determinants of which patients experience hallucinations. The data also provide preliminary evidence that abnormality of the visual system may be related to visual hallucinations in Parkinson's disease, as has been found in other disorders with visual hallucinations.

Entities:  

Mesh:

Year:  2001        PMID: 11385005      PMCID: PMC1737419          DOI: 10.1136/jnnp.70.6.734

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  26 in total

1.  Introduction.

Authors: 
Journal:  Semin Clin Neuropsychiatry       Date:  1998-01

Review 2.  Psychosis: impact on the patient and family.

Authors:  E Melamed; G Friedberg; J Zoldan
Journal:  Neurology       Date:  1999       Impact factor: 9.910

3.  Research diagnostic criteria for Parkinson's disease.

Authors:  C D Ward; W R Gibb
Journal:  Adv Neurol       Date:  1990

4.  Hallucinations in Parkinson disease: neuropsychological study.

Authors:  G Meco; V Bonifati; G Cusimano; E Fabrizio; N Vanacore
Journal:  Ital J Neurol Sci       Date:  1990-08

5.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

6.  Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study.

Authors:  D Aarsland; J P Larsen; J L Cummins; K Laake
Journal:  Arch Neurol       Date:  1999-05

7.  Validating the GDS depression screen in the nursing home.

Authors:  S A McGivney; M Mulvihill; B Taylor
Journal:  J Am Geriatr Soc       Date:  1994-05       Impact factor: 5.562

8.  Assessment of depression in geriatric medical outpatients: the validity of two screening measures.

Authors:  J T Norris; D Gallagher; A Wilson; C H Winograd
Journal:  J Am Geriatr Soc       Date:  1987-11       Impact factor: 5.562

9.  Mortality and hallucinations in nursing home patients with advanced Parkinson's disease.

Authors:  C G Goetz; G T Stebbins
Journal:  Neurology       Date:  1995-04       Impact factor: 9.910

10.  Psychotic symptoms in Parkinson's disease patients with dementia.

Authors:  D Naimark; E Jackson; E Rockwell; D V Jeste
Journal:  J Am Geriatr Soc       Date:  1996-03       Impact factor: 5.562

View more
  64 in total

Review 1.  Sharpening the boundaries of Parkinson-associated dementia: recommendation for a neuropsychological diagnostic procedure.

Authors:  Marc R Bothe; Ingo Uttner; Markus Otto
Journal:  J Neural Transm (Vienna)       Date:  2010-01-30       Impact factor: 3.575

Review 2.  Psychotic symptoms in Parkinson's disease. From description to etiology.

Authors:  Spiridon Papapetropoulos; D C Mash
Journal:  J Neurol       Date:  2005-07       Impact factor: 4.849

Review 3.  Recognition and management of neuropsychiatric complications in Parkinson's disease.

Authors:  Florian Ferreri; Catherine Agbokou; Serge Gauthier
Journal:  CMAJ       Date:  2006-12-05       Impact factor: 8.262

4.  Relationship between age and subtypes of psychotic symptoms in Parkinson's disease.

Authors:  Günes Kiziltan; Sibel Ozekmekçi; Sibel Ertan; Turan Ertan; Ethem Erginöz
Journal:  J Neurol       Date:  2007-03-31       Impact factor: 4.849

5.  Frequency and correlates of co-morbid psychosis and depression in Parkinson's disease.

Authors:  Daniel Weintraub; Knashawn H Morales; John E Duda; Paul J Moberg; Matthew B Stern
Journal:  Parkinsonism Relat Disord       Date:  2006-06-22       Impact factor: 4.891

6.  Clinical and pathologic presentation in Parkinson's disease by apolipoprotein e4 allele status.

Authors:  Sarah E Monsell; Lilah M Besser; Katherine B Heller; Harvey Checkoway; Irene Litvan; Walter A Kukull
Journal:  Parkinsonism Relat Disord       Date:  2014-02-13       Impact factor: 4.891

7.  Delusions in Parkinson's Disease: A Systematic Review of Published Cases.

Authors:  Nicola Warren; Cullen O'Gorman; Zena Hume; Steve Kisely; Dan Siskind
Journal:  Neuropsychol Rev       Date:  2018-08-02       Impact factor: 7.444

Review 8.  Pathophysiology and treatment of psychosis in Parkinson's disease: a review.

Authors:  Laura B Zahodne; Hubert H Fernandez
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 9.  Psychiatric aspects of Parkinson's disease--an update.

Authors:  Anette Schrag
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

Review 10.  Current Understanding of Psychosis in Parkinson's Disease.

Authors:  Oluwadamilola O Ojo; Hubert H Fernandez
Journal:  Curr Psychiatry Rep       Date:  2016-10       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.